N-[(E)-[(8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene]amino]acetamide

C31H52N2O — CID 20836461

IUPACN-[(E)-[(8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene]amino]acetamide
SMILESCC(=O)N/N=C1\CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1(C)C
InChIInChI=1S/C31H52N2O/c1-20(2)10-9-11-21(3)24-13-14-25-23-12-15-27-29(5,6)28(33-32-22(4)34)17-19-31(27,8)26(23)16-18-30(24,25)7/h15,20-21,23-26H,9-14,16-19H2,1-8H3,(H,32,34)/b33-28+/t21-,23+,24-,25+,26+,30-,31-/m1/s1
InChIKeyRCFQMFZAFWOVMT-HONOXQLJSA-N
MW468.77 g/mol
LogP8.16
Rot. Bonds6

About N-[(E)-[(8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene]amino]acetamide

N-[(E)-[(8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene]amino]acetamide (PubChem CID 20836461) has the molecular formula C31H52N2O and a molecular weight of 468.77 g/mol. Its IUPAC name is N-[(E)-[(8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene]amino]acetamide.

Molecular Properties

Compound NameN-[(E)-[(8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene]amino]acetamide
PubChem CID20836461
Molecular FormulaC31H52N2O
Molecular Weight468.77 g/mol
Exact Mass468.41
IUPAC NameN-[(E)-[(8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene]amino]acetamide
SMILESCC(=O)N/N=C1\CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1(C)C
InChIInChI=1S/C31H52N2O/c1-20(2)10-9-11-21(3)24-13-14-25-23-12-15-27-29(5,6)28(33-32-22(4)34)17-19-31(27,8)26(23)16-18-30(24,25)7/h15,20-21,23-26H,9-14,16-19H2,1-8H3,(H,32,34)/b33-28+/t21-,23+,24-,25+,26+,30-,31-/m1/s1
InChIKeyRCFQMFZAFWOVMT-HONOXQLJSA-N
XLogP8.16
TPSA41.46 Ų
H-Bond Donors1
H-Bond Acceptors2
Rotatable Bonds6
Heavy Atoms34
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500468.77
LogP ≤ 58.16
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 102

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze N-[(E)-[(8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene]amino]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(E)-[(8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene]amino]acetamide?
The IUPAC name of N-[(E)-[(8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene]amino]acetamide (CID 20836461) is N-[(E)-[(8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene]amino]acetamide.
What is the SMILES notation for N-[(E)-[(8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene]amino]acetamide?
The canonical SMILES for N-[(E)-[(8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene]amino]acetamide is CC(=O)N/N=C1\CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1(C)C.
What is the InChIKey of N-[(E)-[(8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene]amino]acetamide?
The InChIKey is RCFQMFZAFWOVMT-HONOXQLJSA-N. The full InChI is InChI=1S/C31H52N2O/c1-20(2)10-9-11-21(3)24-13-14-25-23-12-15-27-29(5,6)28(33-32-22(4)34)17-19-31(27,8)26(23)16-18-30(24,25)7/h15,20-21,23-26H,9-14,16-19H2,1-8H3,(H,32,34)/b33-28+/t21-,23+,24-,25+,26+,30-,31-/m1/s1.
What are the key properties of N-[(E)-[(8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene]amino]acetamide?
N-[(E)-[(8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene]amino]acetamide has a molecular weight of 468.77 g/mol, XLogP of 8.16, 6 rotatable bonds, 1 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(E)-[(8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene]amino]acetamide is sourced from PubChem (CID 20836461), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).